By regularly monitoring the concentration of exhaled trace gas chemicals in a patient’s breath it is possible to help asthma sufferers control their condition before they even develop any symptoms.
Breath analysis can be used as a point of care diagnostic tool for disease management. Regular monitoring leads to more effective patient treatment and reduction of healthcare costs.
Mobile Health, supported by the use of mobile phones and other wireless devices improves the delivery of healthcare information to practitioners and real-time monitoring of patient vital signs.
Diagnostic testings improve the quality of healthcare provided and to reduce healthcare costs through shorter hospital visits and ensuring treatment is relevant and more cost-effective.
Dr Victor Higgs was one of the key note speakers at the MTA-Cranfield Surface Engineering and Applied Nanotechnology: OPEN One-day Conference (31st March 2017, Cranfield University). This open conference focused on a range of technology related issues, including future strategies and opportunities in development and collaboration, for the surface engineering industry and nanotechnology companies in the UK
{ 0 comments }
Dr Victor Higgs, was part of a panel discussion at Genesis 2016 (1st December 2016) on Can Employers Revolutionise Med Tech Funding? There was a very active discussion, and there a number of possible solutions presented. Dr Victor Higgs talked about Applied Nanodetectors breath analyser for chronic disease management which has helped employees to become more engaged and also become more aware of self-managment techniques.
{ 0 comments }